Life Sciences & Biotechnology
Title : | Stem cell derived exosome therapy for clinical management of lung damage in critically-ill corona viral pneumonia patients |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology |
Focus area : | Exosome therapy |
Principal Investigator : | Dr Naresh Kasoju, Scientist, Sree Chitra Tirunal Institute for Medical Sciences &Technology (SCTIMST), Thiruvananthapuram |
Timeline Start Year : | 2020 |
Contact info : | naresh.kasoju@gmail.com |
Details
Executive Summary : | This study hypothesized that the immuno-modulatory and the reparative properties of MSC-derived exosomal fractions will aid in controlling the cytokine storm and the lung tissue regeneration in the critically ill COVID-19 patients. |
Organizations involved